Code and data for Keynote 522 economic model

$1.00

All your purchased models will be available under your account under “Dashboards”

Disease Area (Primary)

Triple negative breast cancer

Disease Area (Secondary)

First Developed

05/29/2023

Last Developed

06/01/2023

Software Used

Microsoft Excel

Model Sponsor

Unknown

Intervention

pembrolizumab

Model Validation Score

75 %

Coming Soon In Phase II:  You will be able to pay a fee to download the CADTH Tool for your model which includes subaggregated scores.

Results

NA

Conclusion

NA

Source File(s)

Publication File:
Publication File 1:
Publication File 2:
Publication File 3:
Publication File 4:

No link submitted.

No link submitted.

No link submitted.

No link submitted.

No link submitted.


Model Review

Only visible for the model owner

Summary
Validation Score

75 %

Internal Comments